zlacker

>>giulio+(OP)
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024.

I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US.

In my friend circle in Germany I don't even know one single person on this stuff.

It's insane to me that so many people need these to get off the processed foods killing them in the US.

>>carlmr+B5
Your friend circle in Germany probably doesn't have many members who were a proud big boned 5"7' 300lbs (~140kg).

>>blitza+E6
For good reason.

That'd be a BMI of 47. There isn't a lot of statistical data for such high BMIs, but [1] lists prevalence of BMI>40. In Germany 1.2% of men and 2.8% of women had a BMI over 40 in 2011, in the US it was 5.6% and 9.7% respectively in 2016. That's nearly four times as many as in Germany.

1: https://pmc.ncbi.nlm.nih.gov/articles/PMC7078951/

>>wongar+4a
But prior to GLP-1s, obesity rates were growing rapidly in Germany. Doubled over 3 decades - https://www.sciencedirect.com/science/article/abs/pii/S15706...

Most of the industrialized west is following very similar growth curves here to the US. America just got their first. Even Asia isn't immune - Korea has been following similar trends, as have parts of southeast asia, etc.

I suspect the prevalence of GLP-1 class drugs will halt this trend before the rest of the world catches up, but without them or similar drugs, I would have bet that 50 years form now much of the rest of the world would look just like America